A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
第一作者:
Andrew F,Berdel
第一单位:
Department of Medicine A, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
作者:
医学主题词
人类(Humans);老年人(Aged);老年人, 80以上(Aged, 80 and over);阿糖胞苷(Cytarabine);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);吲哚类(Indoles)
DOI
10.1007/s00277-022-05025-0
PMID
36399194
发布时间
2023-04-26
- 浏览0
Annals of hematology
63-72页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



